VCH-916 free base

Category	Hepatitis C Virus (HCV)
CAS	914778-92-0
Description	VCH-916 is a novel allosteric inhibitor of HCV NS5B polymerase. The RNA-dependent RNA polymerase (NS5B) of HCV is one of the attractive validated targets for development of new drugs to block HCV infection. VCH-916 is currently being evaluated for safety/tolerability, pharmacokinetics and anti-viral efficacy in chronically infected HCV patient.

Quotation Now

Synonyms	914778-92-0;SCHEMBL2105915;SCHEMBL2105916;SCHEMBL2105918;SCHEMBL2105945;SCHEMBL2106562;SCHEMBL2106564;SCHEMBL4541440;CHEMBL3186023;CHEMBL4303412;NCGC00346467-01;TS-10647;BRD-K75956464-237-01-5;5-(cyclohex-1-en-1-yl)-3-{N-[(1r,4r)-4-methoxycyclohexyl](1r,4r)-4-methylcyclohexaneamido}thiophene-2-carboxylic acid;
IUPAC Name	5-(cyclohexen-1-yl)-3-[(4-methoxycyclohexyl)-(4-methylcyclohexanecarbonyl)amino]thiophene-2-carboxylic acid
Molecular Weight	372.3
Molecular Formula	C18H12O9
Canonical SMILES	C1=C(C=C(C=C1O)OC2=C(C=C(C3=C2OC4=C(C=C(C=C4O3)O)O)O)O)O
InChI	InChI=1S/C26H37NO4S/c1-17-8-10-19(11-9-17)25(28)27(20-12-14-21(31-2)15-13-20)22-16-23(32-24(22)26(29)30)18-6-4-3-5-7-18/h6,16-17,19-21H,3-5,7-15H2,1-2H3,(H,29,30)
InChIKey	LNYKGELUODVSNS-UHFFFAOYSA-N
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.